Giansanti Fabrizio, Dragotto Francesco, Nicolosi Cristina, Alonzo Ludovica, Cifarelli Lorenzo, Franco Fabrizio Gaetano Saverio, Vannozzi Lorenzo, Abbruzzese Giacomo, Bacherini Daniela, Virgili Gianni
Department of Neurosciences, Psychology, Drug Research and Child Health, Eye Clinic, University of Florence, AOU Careggi, 50121 Florence, Italy.
J Clin Med. 2023 Jul 30;12(15):5016. doi: 10.3390/jcm12155016.
The aim of this research was to see if a refractive enhanced monofocal IOL (Eyhance IOL, IOL Abbott Medical Optics, Inc., Santa Ana, CA, USA) can provide better intermediate vision in patients undergoing phaco-vitrectomy due to cataract and epiretinal macular membrane (ERM).
A nonrandomized prospective observational comparative study enrolled patients affected by cataract and ERM undergoing phaco-vitrectomy. A follow up of 6 months was established. Corrected and uncorrected visual acuity of both monocular and binocular types were assessed regarding intermediate and far distances. The CATQUEST 9-SF questionnaire was administered preoperatively and at the last follow-up.
Twenty-three eyes of twenty-three patients were enrolled, with 11 in the enhanced monofocal group. The uncorrected and corrected distance visual acuity after 6 months was not statistically different. Both monocular and binocular uncorrected intermediate visual acuity after 6 months were higher in the enhanced monofocal group ( < 0.001). The corrected intermediate visual acuity after 6 months was higher in the enhanced monofocal group ( = 0.01). The CATQUEST-9SF questionnaire showed significant differences in the variation between the preoperative condition and six-month postoperative results ( < 0.001).
This refractive enhanced monofocal IOL can provide better intermediate vision compared to a standard monofocal IOL in patients undergoing phaco-vitrectomy due to cataracts and ERM. Further studies are necessary to confirm these results.
本研究的目的是探讨一种屈光性增强型单焦点人工晶状体（Eyhance人工晶状体，美国加利福尼亚州圣安娜市雅培医疗光学公司）能否为因白内障和视网膜前黄斑膜（ERM）而接受超声乳化玻璃体切除术的患者提供更好的中间视力。
一项非随机前瞻性观察性对比研究纳入了因白内障和ERM而接受超声乳化玻璃体切除术的患者。设定了6个月的随访期。评估了单眼和双眼在中间距离和远距离的矫正及未矫正视力。术前及最后一次随访时使用CATQUEST 9-SF问卷进行调查。
纳入了23例患者的23只眼，其中增强型单焦点组11只眼。6个月后的未矫正及矫正远距离视力无统计学差异。增强型单焦点组6个月后的单眼和双眼未矫正中间视力均更高（P<0.001）。增强型单焦点组6个月后的矫正中间视力更高（P = 0.01）。CATQUEST-9SF问卷显示术前状况与术后6个月结果之间的差异有统计学意义（P<0.001）。
对于因白内障和ERM而接受超声乳化玻璃体切除术的患者，这种屈光性增强型单焦点人工晶状体相比标准单焦点人工晶状体可提供更好的中间视力。需要进一步研究以证实这些结果。
